IAVI to Accelerate Promising Investigational Sudan Ebolavirus Vaccine Development for
Merck will provide the investigational vaccine based on a proven platform technology NEW YORK, NY / ACCESSWIRE / October 25, 2022 / IAVI, a nonprofit scientific research Read More